Controlled release formulations with continuous efficacy

Details for Australian Patent Application No. 2010206376 (hide)

Owner Egalet Ltd.

Inventors Andersen, Christine; Jespersen, Lillian; Lindhardt, Karsten; Overgard, Jan Martin; Lyhne-Iversen, Louise Inoka; Olsen, Martin Rex; Christensen, Lars Hedevang; Hoilund-Jensen, Jacob Aas

Agent FB Rice

Pub. Number AU-B-2010206376

PCT Pub. Number WO2010/083843

Priority PA 2009 00782 24.06.09 DK; PA 2009 00127 26.01.09 DK; 61/147,151 26.01.09 US

Filing date 26 January 2010

Wipo publication date 29 July 2010

Acceptance publication date 18 October 2012

International Classifications

A61K 9/22 Medicinal preparations characterised by special physical form - Sustained or differential release type

A61K 9/20 Medicinal preparations characterised by special physical form - Pills, lozenges or tablets

A61K 9/28 Medicinal preparations characterised by special physical form - Dragees

A61K 9/36 Medicinal preparations characterised by special physical form

A61K 31/485 - Morphinan derivatives, e.g. morphine, codeine

Event Publications

11 August 2011 PCT application entered the National Phase

  PCT publication WO2010/083843 Priority application(s): WO2010/083843

8 March 2012 Assignment before Grant

  Egalet A/S The application has been assigned to Egalet Ltd.

18 October 2012 Application Accepted

  Published as AU-B-2010206376

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2010206469-Production of soluble soy protein product from soy protein micellar mass ("S200Ca")

2010206374-Improved cell lines and their use in encapsulated cell biodelivery